Recursion, Enamine generate 10 enriched libraries for drug discovery.
AinvestWednesday, Apr 9, 2025 8:11 am ET
1min read Recursion, a clinical stage TechBio company, has collaborated with Enamine to create 10 screening libraries from over 15,000 synthesized compounds. The libraries aim to accelerate drug discovery against 100 key targets in challenging biological areas using Enamine's REAL Space chemical library and Recursion's AI/ML platform. The collaboration aims to improve drug discovery and overcome the challenges of navigating the vast chemical space.
View Source
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
_a5aa6a1f1748879890986.jpeg)
_a05abc0b1748876871987.jpeg)
